Abbott Laboratories - 46 Year Stock Price History | ABT
Historical daily share price chart and data for Abbott Laboratories since 1980 adjusted for splits and dividends. The latest closing stock price for Abbott Laboratories as of February 17, 2026 is 112.26.
- The all-time high Abbott Laboratories stock closing price was 137.64 on March 03, 2025.
- The Abbott Laboratories 52-week high stock price is 141.23, which is 25.8% above the current share price.
- The Abbott Laboratories 52-week low stock price is 105.27, which is 6.2% below the current share price.
- The average Abbott Laboratories stock price for the last 52 weeks is 128.63.
| Abbott Laboratories Historical Annual Stock Price Data | ||||||
|---|---|---|---|---|---|---|
| Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
| 2026 | 115.7212 | 123.5640 | 127.1360 | 106.0500 | 112.2600 | -9.95% |
| 2025 | 127.8812 | 110.7690 | 137.6370 | 109.0540 | 124.6590 | 12.87% |
| 2024 | 107.9733 | 105.1600 | 116.5790 | 97.2513 | 110.4470 | 4.82% |
| 2023 | 98.9788 | 102.8440 | 109.1230 | 86.3397 | 105.3710 | 2.26% |
| 2022 | 104.1754 | 128.3400 | 128.3400 | 89.2170 | 103.0420 | -20.68% |
| 2021 | 111.5091 | 99.1803 | 130.5740 | 96.9044 | 129.9090 | 30.53% |
| 2020 | 86.8896 | 77.8103 | 104.0070 | 56.4555 | 99.5257 | 28.04% |
| 2019 | 71.6345 | 61.1798 | 79.0950 | 58.2925 | 77.7298 | 22.08% |
| 2018 | 56.1549 | 50.8206 | 65.3788 | 48.8748 | 63.6711 | 29.06% |
| 2017 | 41.6341 | 32.9911 | 49.6795 | 32.9911 | 49.3338 | 52.03% |
| 2016 | 33.8735 | 35.3786 | 38.0212 | 30.1368 | 32.4504 | -12.32% |
| 2015 | 37.8358 | 36.2351 | 41.9522 | 32.0049 | 37.0103 | 1.87% |
| 2014 | 32.7773 | 30.1766 | 37.4214 | 28.4561 | 36.3319 | 20.08% |
| 2013 | 27.9642 | 24.8921 | 30.5554 | 24.8921 | 30.2555 | 23.96% |
| 2012 | 23.1131 | 20.4671 | 26.8788 | 19.7083 | 24.4081 | 20.30% |
| 2011 | 18.1655 | 16.6306 | 20.3263 | 15.8513 | 20.2902 | 21.78% |
| 2010 | 17.3991 | 18.3220 | 19.0590 | 15.6722 | 16.6619 | -8.27% |
| 2009 | 16.0782 | 17.4318 | 18.7677 | 13.7349 | 18.1638 | 4.57% |
| 2008 | 17.7598 | 17.7048 | 19.3265 | 16.0942 | 17.3700 | -2.49% |
| 2007 | 17.1020 | 15.1705 | 18.6851 | 15.1705 | 17.8127 | 18.04% |
| 2006 | 13.8105 | 11.9308 | 15.2314 | 11.9308 | 15.0900 | 26.86% |
| 2005 | 13.5509 | 13.7542 | 14.9000 | 11.3516 | 11.8946 | -13.48% |
| 2004 | 11.8262 | 11.7081 | 13.8485 | 9.9095 | 13.7483 | 17.80% |
| 2003 | 10.2450 | 9.7971 | 11.8083 | 8.4600 | 11.6706 | 19.27% |
| 2002 | 11.1071 | 13.3767 | 13.8751 | 7.5390 | 9.7848 | -26.73% |
| 2001 | 11.9171 | 11.3335 | 13.5995 | 9.9492 | 13.3552 | 17.08% |
| 2000 | 9.7640 | 8.0937 | 13.1291 | 6.8844 | 11.4070 | 35.84% |
| 1999 | 10.0226 | 11.1083 | 12.1408 | 7.7035 | 8.3972 | -24.79% |
| 1998 | 9.2716 | 7.5696 | 11.3362 | 7.4854 | 11.1653 | 51.87% |
| 1997 | 6.8668 | 5.5298 | 7.7029 | 5.5298 | 7.3521 | 31.97% |
| 1996 | 4.9391 | 4.4861 | 6.2297 | 4.1847 | 5.5710 | 24.56% |
| 1995 | 4.1009 | 3.4418 | 4.7701 | 3.3038 | 4.4726 | 30.45% |
| 1994 | 3.0878 | 2.9580 | 3.5337 | 2.6917 | 3.4286 | 12.98% |
| 1993 | 2.7217 | 3.0343 | 3.0733 | 2.3347 | 3.0348 | 0.02% |
| 1992 | 3.0409 | 3.2953 | 3.3423 | 2.6689 | 3.0343 | -10.09% |
| 1991 | 2.5339 | 2.0780 | 3.3749 | 1.9198 | 3.3749 | 56.10% |
| 1990 | 1.8180 | 1.6282 | 2.1861 | 1.4888 | 2.1620 | 35.23% |
| 1989 | 1.3779 | 1.0962 | 1.6487 | 1.0772 | 1.5988 | 44.71% |
| 1988 | 1.0643 | 1.0894 | 1.1712 | 0.9742 | 1.1048 | 2.21% |
| 1987 | 1.2741 | 1.0414 | 1.4724 | 0.9633 | 1.0809 | 8.07% |
| 1986 | 0.9555 | 0.7312 | 1.1815 | 0.6891 | 1.0002 | 36.04% |
| 1985 | 0.5808 | 0.4253 | 0.7540 | 0.4201 | 0.7352 | 68.20% |
| 1984 | 0.4443 | 0.4685 | 0.4986 | 0.3978 | 0.4371 | -5.14% |
| 1983 | 0.4591 | 0.3689 | 0.5398 | 0.3671 | 0.4608 | 19.29% |
| 1982 | 0.3195 | 0.2692 | 0.4001 | 0.2530 | 0.3863 | 43.50% |
| 1981 | 0.2816 | 0.2835 | 0.3153 | 0.2393 | 0.2692 | -4.44% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $195.936B | $44.328B |
| Abbott Labs discovers, develops, manufactures & sells a diversified line of health care products. Established Pharmaceuticals Division includes branded generics business in the emerging markets. Medical Devices unit includes the diabetes care, vision care & vascular businesses. Diagnostics unit manufactures and markets diagnostic systems and tests in four business lines core laboratory, molecular, point of care and rapid diagnostics. Nutrition unit includes a broad line of pediatric and adult nutritional products. Abbott acquired CFR Pharmaceuticals, Tendyne Holdings, Inc., St. Jude Medical and Alere Inc. On the other hand, Abbott sold its developed markets branded generics pharmaceuticals business to Mylan. Abbott retained the branded generics pharmaceuticals business in emerging markets. Abbott sold its animal health business to Zoetis Inc and divested its vision care business, Medical Optics, to Johnson & Johnson. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| EssilorLuxottica (ESLOY) | France | $142.091B | 0.00 |
| Stryker (SYK) | United States | $140.083B | 26.86 |
| Medtronic (MDT) | Ireland | $127.548B | 17.67 |
| Boston Scientific (BSX) | United States | $110.783B | 24.50 |
| Medline (MDLN) | United States | $58.526B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $48.093B | 0.00 |
| ResMed (RMD) | United States | $36.791B | 24.57 |
| GE HealthCare Technologies (GEHC) | United States | $36.615B | 17.54 |
| Agilent Technologies (A) | United States | $35.584B | 22.55 |
| Koninklijke Philips (PHG) | Netherlands | $30.091B | 17.86 |
| Terumo (TRUMY) | Japan | $21.610B | 25.26 |
| Zimmer Biomet Holdings (ZBH) | United States | $19.115B | 11.76 |
| Insulet (PODD) | United States | $17.076B | 53.00 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $15.372B | 0.00 |
| Baxter (BAX) | United States | $10.182B | 8.72 |
| Sunny Optical Technology (SNPTF) | China | $8.485B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.921B | 25.86 |
| Demant (WILYY) | Denmark | $6.042B | 0.00 |
| Envista Holdings (NVST) | United States | $4.747B | 24.14 |
| Lantheus Holdings (LNTH) | United States | $4.601B | 14.02 |
| BillionToOne (BLLN) | United States | $4.056B | 0.00 |
| ICU Medical (ICUI) | United States | $3.577B | 22.71 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.263B | 0.00 |
| Prestige Consumer Healthcare (PBH) | United States | $3.160B | 14.91 |
| Haemonetics (HAE) | United States | $2.684B | 11.74 |
| Neogen (NEOG) | United States | $2.380B | 52.10 |
| Phibro Animal Health (PAHC) | United States | $2.118B | 18.66 |
| Perrigo (PRGO) | Ireland | $2.001B | 5.01 |
| LeMaitre Vascular (LMAT) | United States | $1.989B | 40.03 |
| Curaleaf Holdings (CURLF) | Canada | $1.642B | 0.00 |
| AtriCure (ATRC) | United States | $1.623B | 0.00 |
| QuidelOrtho (QDEL) | United States | $1.602B | 11.12 |
| Kestra Medical Technologies (KMTS) | United States | $1.571B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.446B | 63.36 |
| AdaptHealth (AHCO) | United States | $1.381B | 20.00 |
| Lumexa Imaging Holdings (LMRI) | United States | $1.358B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.070B | 317.57 |
| Capricor Therapeutics (CAPR) | United States | $1.026B | 0.00 |
| InMode (INMD) | Israel | $0.906B | 9.93 |
| Tilray Brands (TLRY) | Canada | $0.875B | 0.00 |
| Valneva SE (VALN) | France | $0.868B | 0.00 |
| Omeros (OMER) | United States | $0.829B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.757B | 0.00 |
| CeriBell (CBLL) | United States | $0.733B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.566B | 13.52 |
| Brainsway (BWAY) | Israel | $0.451B | 76.63 |
| Canopy Growth (CGC) | Canada | $0.436B | 0.00 |
| Cerus (CERS) | United States | $0.430B | 0.00 |
| Verano Holdings (VRNO) | United States | $0.396B | 0.00 |
| SNDL (SNDL) | Canada | $0.386B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.361B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.328B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.315B | 25.09 |
| Evolus (EOLS) | United States | $0.279B | 0.00 |
| Quanterix (QTRX) | United States | $0.268B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.243B | 0.00 |
| Owens & Minor (OMI) | United States | $0.217B | 2.17 |
| Sanuwave Health (SNWV) | United States | $0.213B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.205B | 18.42 |
| High Tide (HITI) | Canada | $0.203B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.201B | 59.17 |
| OraSure Technologies (OSUR) | United States | $0.197B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.182B | 0.00 |
| Organigram Global (OGI) | Canada | $0.174B | 0.00 |
| Accendra Health (ACH) | United States | $0.173B | 1.74 |
| Vireo Growth (VREOF) | United States | $0.170B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.168B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.157B | 0.00 |
| Apyx Medical (APYX) | United States | $0.142B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.134B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.129B | 0.00 |
| Fonar (FONR) | United States | $0.115B | 16.42 |
| MacroGenics (MGNX) | United States | $0.108B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.100B | 0.00 |
| Biote (BTMD) | United States | $0.097B | 4.26 |
| Exagen (XGN) | United States | $0.074B | 0.00 |
| ImmuCell (ICCC) | United States | $0.060B | 25.39 |
| Sharps Technology (STSS) | United States | $0.051B | 0.00 |
| Nephros (NEPH) | United States | $0.044B | 31.54 |
| Cytosorbents (CTSO) | United States | $0.040B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.040B | 0.00 |
| Veru (VERU) | United States | $0.037B | 0.00 |
| Modular Medical (MODD) | United States | $0.035B | 0.00 |
| United-Guardian (UG) | United States | $0.030B | 15.35 |
| Jin Medical (ZJYL) | China | $0.022B | 0.00 |
| Bonk (BNKK) | United States | $0.021B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.014B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.014B | 0.00 |
| Flora Growth (FLGC) | United States | $0.009B | 0.00 |
| INLIF (INLF) | China | $0.007B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.006B | 0.00 |
| Zynex (ZYXI) | United States | $0.004B | 0.00 |
| Functional Brands (MEHA) | United States | $0.003B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.002B | 0.00 |
| Agape ATP (ATPC) | $0.002B | 0.00 | |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.002B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.000B | 0.00 |